Ruth Forman

Ruth Forman is a Researcher in the Division of Cancer Sciences, contributing to immunoparasitology and helminth infection research. She holds a Ph.D. from 2011, focusing on interferon gamma signaling in immune responses. Her work bridges basic science and translational research, particularly in anthelmintic drug discovery and host-parasite interactions. Key projects include studies on Trichuris muris pathogenesis, macrophage responses, and drug efficacy against parasitic worms. She has co-authored over 18 peer-reviewed articles and contributed to datasets on intestinal inflammation and parasite susceptibility. Collaborations span parasitology, microbiology, and drug discovery. Her research aligns with UN Sustainable Development Goals related to health and environmental sustainability.

• Education: Ph.D. in Immunology (2011)
• Research Themes: Immune responses to helminths, drug discovery, mucosal immunity

Recent work emphasizes holistic discovery approaches using Trichuris muris as a model, with applications in environmental tracking and bio-tagging. She has explored structural requirements for anthelmintics and their efficacy against Schistosoma mansoni and Brugia malayi. Contributions include identifying re-profiled drug leads from the MMV Pandemic Response Box. Ongoing studies investigate macrophage biology in colonic inflammation and cytokine-independent pathways.

Her datasets explore susceptibility of Alzheimer’s mice to infection and roles of eosinophils in IgA regulation. While no formal awards are listed, her work has been cited across immunology and parasitology disciplines.